Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-α (TNF-α) in NB4 leukemic cells: Specific involvement of TNF receptor type 1

Leukemia

Volumn 12, Issue 7, 1998, Pages 1136-1143

  Ismair, M G ^a,b   Ries, C ^a   Lottspeich, F ^c   Zang, C ^a   Kolb, H J ^d   Petrides, P E ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b National Research Center for Environment and Health   (Germany)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^d Harlaching Hospital   (Germany)

Author keywords

Leukemia; Matrix metalloproteinase; NB4; Tissue inhibitor of metalloproteinases; TNF receptors; Tumor necrosis factor

Indexed keywords

METALLOPROTEINASE; PHORBOL 12 ACETATE 13 MYRISTATE; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; AMINO TERMINAL SEQUENCE; ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTER; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PURIFICATION; SEQUENCE ANALYSIS;

EID: 0031851423     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401042     Document Type: Article

References (13)

1. Petrides PE, Dittmann KH. How do normal and leukemic white blood cells egress from the bone marrow? Morphological facts and biochemical riddles. Blut 1990; 61: 3-13.
2. Stetler Stevenson WG, Aznavoorian S, Liotta AL. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993; 9: 541-572.
3. Woessner JFJ. The family of matrix metalloproteinases. Ann NY Acad Sci 1994; 732: 11-21.
4. Liotta LA, and Stetler Stevenson WG. Metalloproteinases and cancer invasion. Semin Cancer Biol 1990; 1: 99-106.
5. Liotta LA, Stetler Stevenson WG, Steeg PS. Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest 1991; 9: 543-551.
6. Alvarez OA, Carmichael DF, DeClerck YA. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst 1990; 82: 589-595.
7. Khokha R, Waterhouse P, Yagel S, Lala PK, Overall CM, Norton G, Denhardt DT. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 1989; 243: 947-950.
8. Sato H, Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 1993; 8: 395-405.
9. Ries C, Kolb H, Petrides PE. Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-alpha as an autocrine stimulus for basal- and phorbol ester-induced secretion. Blood 1994; 83: 3638-3646.
10. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989; 264: 17213-17221.
11. Okada Y, Tsuchiya H, Shimizu H, Tomita K, Nakanishi I, Sato H, Seiki M, Yamashita K, Hayakawa T. Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor a. Biochem Biophys Res Commun 1990; 171: 610-617.
12. Sato H, Kida Y, Mai M, Endo Y, Sasaki T, Tanaka J, Seiki M. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 1992; 7: 77-83.
13. Woessner JFJ. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5: 2145-2154.